Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIFN and Ribavirin for Chronic HCV Genotype 1
NCT00211692Phase 3Completed
- Start
- Jul 2005
- Primary completion
- Jul 2008
- Modality
- Cytokines & Interferons
01
Overview
Phase 3, randomised, open-label trial of interferon alfacon-1 in hepatitis C (HCV). Started Jul 2005; status: completed.
02
Drugs
interferon alfacon-1
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00211692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00211692.